Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

DHEA-S is produced in the adrenal zona reticularis and declines with age.

DHEA-S is primarily synthesized in the adrenal zona reticularis, serves as a stable circulating marker of adrenal androgen output, and decreases markedly with aging.

SupportedJune 19, 202616 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

DHEA-S is produced primarily by the adrenal cortex and functions as a circulating marker of adrenal androgen output that can decline with age.

laying out figure…
All 9 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states most circulating DHEA-S originates from the adrenal zona reticularis and its sulfated form provides a long-lived biomarker of adrenal androgen production. The mechanism framing attributes the age-related decline to structural and enzymatic changes in the zona reticularis that reduce steroid synthesis and substrate availability. Clinically, that stability and adrenal specificity make DHEA-S useful for assessing adrenal function and distinguishing sources of androgen excess.

Verified conclusion

Dehydroepiandrosterone sulfate (DHEA-S) is a specialized steroid hormone that serves as the most abundant circulating precursor to both androgens and estrogens. Its physiological profile is defined by its specific site of origin, its role as a stable indicator of adrenal activity, and its characteristic age-related trajectory.

Clinical and diagnostic utility

Evidence confirms that DHEA-S is the primary circulating marker of adrenal androgen output. Unlike its precursor, DHEA, which has a half-life of only 15–30 minutes, DHEA-S has a significantly longer half-life of 10–20 hours and a lower metabolic clearance rate. This stability makes it a reliable single-point biomarker for clinical assessment.

  • Adrenal insufficiency: DHEA-S levels are highly sensitive markers for diagnosing central adrenal insufficiency, with diagnostic sensitivity ranging from 70% to 89% when adjusted for age.
  • Differential diagnosis: Because its synthesis is regulated by ACTH, DHEA-S can distinguish between types of Cushing syndrome (AUC 0.997) and help identify the source of hyperandrogenism in conditions like PCOS.

Mechanistic basis of production and decline

The production and subsequent age-related decline of DHEA-S are governed by the specialized biology of the adrenal cortex.

  • Site of synthesis: Nearly 90–100% of circulating DHEA-S originates in the zona reticularis (ZR) of the adrenal cortex. This tissue expresses high levels of the enzyme SULT2A1 (sulfotransferase), which converts DHEA into its sulfated form, creating a large systemic reservoir.
  • Adrenopause mechanisms: DHEA-S levels peak in the mid-20s and decline progressively, often reaching only 10–20% of youthful levels by age 70–80. This "adrenopause" is driven by structural atrophy of the ZR and cellular senescence.
  • Molecular drivers: The decline is linked to the accumulation of lipofuscin and aggresomes in ZR cells, alongside a reduction in low-density lipoprotein receptors (LDLR), which limits the cholesterol import required for steroidogenesis.

Bottom line

The claim is fully supported by scientific evidence. DHEA-S is produced almost exclusively in the adrenal zona reticularis and serves as a stable, long-lived marker of adrenal androgenic function. Its levels naturally and significantly decline with age due to structural and enzymatic changes in the adrenal cortex.

References

  1. Regulation of the adrenal androgen biosynthesis — pmc.ncbi.nlm.nih.gov ↗
  2. A New Model for Adrenarche: Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 2 by Intra-Adrenal Cortisol — pmc.ncbi.nlm.nih.gov ↗
  3. Through the Looking-Glass: Reevaluating DHEA Metabolism Through HSD3B1 Genetics — pmc.ncbi.nlm.nih.gov ↗
  4. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. — academic.oup.com ↗
  5. Adrenocorticotropin Acutely Regulates Pregnenolone Sulfate Production by the Human Adrenal In Vivo and In Vitro — pmc.ncbi.nlm.nih.gov ↗
  6. 11-Oxygenated androgens in health and disease — pmc.ncbi.nlm.nih.gov ↗
  7. SAT-167 Dehydroepiandrosterone Sulfate (DHEAS) Levels Predict Weight Gain in Women with Anorexia Nervosa — academic.oup.com ↗
  8. Dehydroepiandrosterone sulfate (DHEAS) as an endocrine marker of aging in calorie restriction studies — pmc.ncbi.nlm.nih.gov ↗
  9. Adrenal Aging: Region-Specific Vulnerability and Proteostatic Decline - Mechanisms, Biomarkers, and Translational Opportunities. — aginganddisease.org ↗
  10. The Sex Hormone Precursors Dehydroepiandrosterone (DHEA) and Its Sulfate Ester Form (DHEAS): Molecular Mechanisms and Actions on Human Body — mdpi.com ↗
  11. A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? — pmc.ncbi.nlm.nih.gov ↗
  12. Plasma dehydroepiandrosterone sulfate and cardiovascular disease risk in older men and women. — pmc.ncbi.nlm.nih.gov ↗
  13. From adrenarche to aging of adrenal zona reticularis: precocious female adrenopause onset — ec.bioscientifica.com ↗
  14. Endocrine and Metabolic Pathways Linked to Keratoconus: Implications for the Role of Hormones in the Stromal Microenvironment — pmc.ncbi.nlm.nih.gov ↗
  15. Ample Evidence: Dehydroepiandrosterone (DHEA) Conversion into Activated Steroid Hormones Occurs in Adrenal and Ovary in Female Rat — pmc.ncbi.nlm.nih.gov ↗
  16. Dehydroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation. — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→